Tweet fijado
Check out our latest paper integrating genomic and functional precision medicine to identify therapeutic vulnerabilities in glioblastoma
nature.com/articles/s4146…
English
NathansonLab
102 posts
NathansonLab
@NathansonLab
Working on a cure for brain cancer — Official lab twitter of the Nathanson Lab at UCLA #gbm #GliomaPDOX #xenografts #braincancer #drugdevelopment
Los Angeles, CA Se unió Eylül 2017
87 Siguiendo343 Seguidores
NathansonLab retuiteado
Today, on #InternationalWomensDay, we’re celebrating NBTS-funded researcher Dr. Elizabeth Fernandez, who just defended her PhD!
Inspired by her cousin’s #braintumor, she’s working to overcome #glioblastoma treatment resistance and advance #precisionmedicine. #WomenInScience
English
QAM
This work was a collaborative effort with @graeber_thomas @SJD956 @jsb_ucla and other colleagues
We are honored for the support and partnership from Pennymac and the Kurland Family Foundation, @NBTStweets @UncleKoryFndn and others
English
Check out our latest paper integrating genomic and functional precision medicine to identify therapeutic vulnerabilities in glioblastoma
nature.com/articles/s4146…
English
We are so honored to be partnering with Pennymac and the Kurland Family Foundation in the fight against brain cancer. Thank you to all the donors and supporters of this cause.
UCLA Neurology@UCLANeurology
Thank you to all of the sponsors and donors at the 3rd Annual Stanford L. Kurland Memorial Golf Classic to benefit brain cancer research at UCLA Neurology. Pennymac raised over $2.3 million in the fight to end brain cancer, as they carry on the legacy of founder, Stan Kurland.
English
Excited for this new year! Looking forward to all the fun science we'll do together.
English
Congratulations Jennifer Salinas, graduate student at
@NathansonLab for advancing to candidacy. We cannot wait to see all the wonderful things you do for your PhD! #Glioblastoma #metabolism
English
Exciting work on trans-differentiation in cancer published in @Cancer_Cell from our colleagues and friends in the @graeber_thomas Lab and Witte Lab at UCLA.
cell.com/cancer-cell/fu…
English
NathansonLab retuiteado
UCLA Brain Tumor Center teams, @UCLANeurology #NeuroOnc @UCLANsgy @NathansonLab, UCLA Brain Tumor Imaging Lab at #sno2023
English
Congratulations Jenna for receiving the Basic Science Award at #SNO2023 for her talk titled 'CDKN2A Deletion Remodels Lipid Metabolism to Prime #Glioblastoma for Ferroptosis'. We are proud of your achievements!
English
Did you check out Elizabeth's wonderful poster about the apoptotic machinery in #glioblastoma #GBM at SNO this weekend?
#SNO2023
English
NathansonLab retuiteado
Congrats to @NathansonLab, @ben_ellingson & Dr. Timothy Cloughesy, who received $2.5M from the @DeptofDefense to develop a tailored treatment for patients with glioblastoma, a deadly brain tumor with limited treatment options.
uclahealth.org/news/researche…
English
Congratulations to our PhD candidate @Marissa_Pioso for receiving the prestigious @theNCI T32 fellowship in Tumor Cell Biology @UCLA to investigate how oncogenic signaling impairs immune response in GBM!
English
In case you missed it, check out our latest paper featured on the cover of the June issue of @Cancer_Cell! 🐻🦊
Cancer Cell@Cancer_Cell
A new issue of Cancer Cell is available now! Check our exciting content for June: cell.com/cancer-cell/is…
Los Angeles, CA 🇺🇸 English
Check out this study co-led by our collaborator, Dr. Timothy Cloughesy, which is the first clinical trial to employ a targeted therapy specifically developed to treat brain tumors.
NEJM@NEJM
Original Article: Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma (INDIGO) nej.md/3N8N5dU #ASCO23
Los Angeles, CA 🇺🇸 English
Read more about this work here: uclahealth.org/news/metabolic…
@UCLAJCCC
English
In collaboration with @SJD956, Steve Bensinger, @TCloughesy, Kevin Williams, @graeber_thomas, and Linda Liau we created a lipidomic and molecular resource of GBM tumors and identified that CDKN2A deletion remodels the GBM lipidome, priming these GBM for ferroptosis.
English
#GBM are lethal, molecularly heterogeneous tumors – it was unknown whether this molecular diversity led to distinct phenotypes and metabolic lipidomic vulnerabilities. New, open access @Cancer_Cell paper: sciencedirect.com/science/articl…
English